Wang and colleagues conducted chromatin immunoprecipitation (ChIP)-based screen for AR-dependent target genes in androgen-dependent and -independent prostate cancer cells and found that AR selectively upregulated M-phase cell-cycle genes in androgen-independent cells, including UBE2C, a gene that inactivates the M-phase checkpoint [82]. Here, AR is linked to prostate cancer.